A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer
about
Novel RING E3 ubiquitin ligases in breast cancerAutoubiquitination of BCA2 RING E3 ligase regulates its own stability and affects cell migrationExpansion and diversification of BTL ring-H2 ubiquitin ligases in angiosperms: putative Rabring7/BCA2 orthologsTrial Watch: Proteasomal inhibitors for anticancer therapyHigh resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphomaProtein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes.BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction.Development and validation of a method for profiling post-translational modification activities using protein microarrays.Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer.Effects of partner proteins on BCA2 RING ligase activity.Role of the BCA2 ubiquitin E3 ligase in hormone responsive breast cancer.Pyruvate dehydrogenase complex deficiency caused by ubiquitination and proteasome-mediated degradation of the E1 subunit.Spliceosomal introns in the 5' untranslated region of plant BTL RING-H2 ubiquitin ligases are evolutionary conserved and required for gene expression.BCA2/Rabring7 targets HIV-1 Gag for lysosomal degradation in a tetherin-independent manner.A Founder Mutation in VPS11 Causes an Autosomal Recessive Leukoencephalopathy Linked to Autophagic DefectsRabring7 degrades c-Myc through complex formation with MM-1Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells.From bortezomib to other inhibitors of the proteasome and beyond.Transcriptional activation of breast cancer-associated gene 2 by estrogen receptorRNF115/BCA2 E3 ubiquitin ligase promotes breast cancer cell proliferation through targeting p21Waf1/Cip1 for ubiquitin-mediated degradation.Antitumor activity of bis-indole derivatives.Expression of transmembrane protein 26 (TMEM26) in breast cancer and its association with drug response.Regulation of metformin response by breast cancer associated gene 2.The Role of BCA2 in the Endocytic Trafficking of EGFR and Significance as a Prognostic Biomarker in Cancer.RNF13: an emerging RING finger ubiquitin ligase important in cell proliferation.Genome-wide copy number analysis in primary breast cancer.Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer ChemotherapeuticsOverexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma.Protein kinase Cvarepsilon mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2).RNF13: a novel RING-type ubiquitin ligase over-expressed in pancreatic cancer.BCA2/Rabring7 Interferes with HIV-1 Proviral Transcription by Enhancing the SUMOylation of IκBα.Regulation of peroxisome proliferator-activated receptors by e6-associated protein.Expression of the novel human gene, UBE2Q1, in breast tumors.E3 ubiquitin ligases in cancer and implications for therapies.Profiling and characterization of microRNAs responding to sodium butyrate treatment in A549 cells.RNF126 as a biomarker of a poor prognosis in invasive breast cancer and CHK1 inhibitor efficacy in breast cancer cells.BCA2 is differentially expressed in renal oncocytoma: an analysis of 158 renal neoplasms.Regulation of DNA Damage Response by Estrogen Receptor β-Mediated Inhibition of Breast Cancer Associated Gene 2.Rare copy number variants analysis identifies novel candidate genes in heterotaxy syndrome patients with congenital heart defects.
P2860
Q24300517-6D388BA8-1290-4B99-A472-6102A31E9024Q24316451-553C8EF0-3E9B-4FBA-AE03-F8A817B47741Q27308811-F19C7505-45B0-4658-AB40-934739375CC5Q28082910-E860E788-7DF1-4BF0-B39A-0AC76C4DF17CQ30873773-3ACCB460-F98D-4851-B529-32CFE83CA19EQ33329750-9CE628B9-1ECA-4BB3-9D58-7B10932B5392Q33519521-99ABDA38-0FC9-4EA5-B258-D214D26A43D6Q33623702-770BE7E4-A843-4956-B11E-ED94C358D392Q33766192-2382C809-186B-4D14-A0F4-3D03F84F82CDQ34153494-3DBBB6F9-B5FA-4B3F-B49D-421D5B6295CBQ34416164-9EC5C3D2-23F7-41EA-9591-76F394F9DA39Q34699604-80655F13-4534-4998-92E0-71AACC8CB6D5Q35042604-5A02FE70-DA8C-47A1-B286-714A85F9DB3DQ35172448-6A89D5BA-E4C2-4434-A9B3-FFA5E91B88DEQ36000935-D7571BC2-B663-4E2E-A19B-5471D8B6554FQ36109554-95A4451C-F663-46F8-B3A3-DF8C3C55EB91Q36837031-4735B922-20FA-4E21-BD95-31DE47AD057EQ36852277-68DD34FA-B7F1-4564-B3D0-631C9F92C32BQ37137658-A8BFC423-2846-4E3E-B6F2-CA9770CA7FB3Q37162378-886E330A-1E93-4814-8834-967D899E7297Q37367541-D6C59605-EB76-46B1-AA52-E41E926F0F1BQ37437522-50BEDA60-FEC0-4B07-9538-26765CAD13B8Q37448089-EC217AF4-E8DE-490B-A59E-9AACA92B6DFFQ37514113-D24F8000-24FF-42FB-881A-3F6DCA4F4F8EQ37809582-72930A62-1BEC-45D9-A3BF-0601239E52CCQ37982127-FCE24E2C-73D0-4325-9560-78C176E45E8DQ38289532-6C8F9C8B-7861-488B-83B8-CEBBBB7D175DQ38700230-E71D5E6A-5AB0-455E-B809-066F4E98AAFEQ39727807-83239EE9-63CB-4936-80FB-D0BBA34A6065Q39939362-CC42A4FC-E65D-46BE-9F7B-C9C5B1835BDEQ40358111-0B334038-9B90-48FD-AAEB-3C266E301B96Q42183885-A1DF5B59-2062-4FA2-A306-DEA0B650FBFDQ42628655-CE4F884F-3357-439B-B2D1-D465926F4EE6Q47636038-CE7C4988-AD0D-409D-9C4F-E0CD6E85E826Q47787181-E1F9A5BD-4397-4B92-AA71-33224EE6E467Q50077606-71851360-CEE3-4993-A49C-18F304866A19Q53129198-AD6040E5-1792-474C-B7DA-A343FAC7DCE5Q53853218-DFBEDF08-E3BD-446B-AA83-9EE250E5D06DQ55116641-3E644B8E-E96E-4AFB-91BE-4D2DA241C7BD
P2860
A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A novel RING-type ubiquitin li ...... come in invasive breast cancer
@ast
A novel RING-type ubiquitin li ...... come in invasive breast cancer
@en
A novel RING-type ubiquitin li ...... come in invasive breast cancer
@en-gb
A novel RING-type ubiquitin li ...... come in invasive breast cancer
@nl
type
label
A novel RING-type ubiquitin li ...... come in invasive breast cancer
@ast
A novel RING-type ubiquitin li ...... come in invasive breast cancer
@en
A novel RING-type ubiquitin li ...... come in invasive breast cancer
@en-gb
A novel RING-type ubiquitin li ...... come in invasive breast cancer
@nl
prefLabel
A novel RING-type ubiquitin li ...... come in invasive breast cancer
@ast
A novel RING-type ubiquitin li ...... come in invasive breast cancer
@en
A novel RING-type ubiquitin li ...... come in invasive breast cancer
@en-gb
A novel RING-type ubiquitin li ...... come in invasive breast cancer
@nl
P2093
P3181
P1433
P1476
A novel RING-type ubiquitin li ...... come in invasive breast cancer
@en
P2093
Angelika M Burger
Arun K Seth
Harriette J Kahn
Richard Kitching
Wedad M Hanna
Yuguang Gao
Yutaka Amemiya
P304
P3181
P356
10.1158/0008-5472.CAN-05-2103
P407
P577
2005-11-15T00:00:00Z